CNR1 and cancer: The response of cancers such as those of the bladder, pancreas, small intestine and prostate, as well as keratinocyte and neuroblastoma cell lines [18] to endocannabinoid-like ligands, occurs in a non-CB1/CB2-dependent manner [9].